ArticleActa pharmaceutica Sinica. B2023

Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy.

Xiaoshuang Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.